Logo image of HZO

MARINEMAX INC (HZO) Stock Fundamental Analysis

USA - NYSE:HZO - US5679081084 - Common Stock

25.76 USD
-0.24 (-0.92%)
Last: 9/25/2025, 7:25:14 PM
25.76 USD
0 (0%)
After Hours: 9/25/2025, 7:25:14 PM
Fundamental Rating

3

Taking everything into account, HZO scores 3 out of 10 in our fundamental rating. HZO was compared to 122 industry peers in the Specialty Retail industry. HZO has a medium profitability rating, but doesn't score so well on its financial health evaluation. HZO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

HZO had positive earnings in the past year.
In the past year HZO had a positive cash flow from operations.
Each year in the past 5 years HZO has been profitable.
In multiple years HZO reported negative operating cash flow during the last 5 years.
HZO Yearly Net Income VS EBIT VS OCF VS FCFHZO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

HZO has a Return On Assets (-1.08%) which is comparable to the rest of the industry.
With a Return On Equity value of -2.85%, HZO perfoms like the industry average, outperforming 46.72% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 3.78%, HZO is in line with its industry, outperforming 53.28% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for HZO is below the industry average of 12.02%.
The last Return On Invested Capital (3.78%) for HZO is well below the 3 year average (9.69%), which needs to be investigated, but indicates that HZO had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.08%
ROE -2.85%
ROIC 3.78%
ROA(3y)6.87%
ROA(5y)9.12%
ROE(3y)13.71%
ROE(5y)16.71%
ROIC(3y)9.69%
ROIC(5y)12.16%
HZO Yearly ROA, ROE, ROICHZO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

HZO's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 5.00%, HZO is in the better half of the industry, outperforming 68.03% of the companies in the same industry.
In the last couple of years the Operating Margin of HZO has grown nicely.
With a Gross Margin value of 32.41%, HZO is not doing good in the industry: 60.66% of the companies in the same industry are doing better.
HZO's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5%
PM (TTM) N/A
GM 32.41%
OM growth 3Y-19.61%
OM growth 5Y1.53%
PM growth 3Y-40.71%
PM growth 5Y-11.66%
GM growth 3Y1.03%
GM growth 5Y4.78%
HZO Yearly Profit, Operating, Gross MarginsHZO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HZO is creating some value.
Compared to 1 year ago, HZO has more shares outstanding
Compared to 5 years ago, HZO has more shares outstanding
The debt/assets ratio for HZO is higher compared to a year ago.
HZO Yearly Shares OutstandingHZO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HZO Yearly Total Debt VS Total AssetsHZO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 1.82 indicates that HZO is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of HZO (1.82) is comparable to the rest of the industry.
A Debt/Equity ratio of 1.17 is on the high side and indicates that HZO has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.17, HZO is doing worse than 62.30% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF N/A
Altman-Z 1.82
ROIC/WACC0.41
WACC9.15%
HZO Yearly LT Debt VS Equity VS FCFHZO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

HZO has a Current Ratio of 1.21. This is a normal value and indicates that HZO is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of HZO (1.21) is worse than 61.48% of its industry peers.
A Quick Ratio of 0.29 indicates that HZO may have some problems paying its short term obligations.
The Quick ratio of HZO (0.29) is worse than 77.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.29
HZO Yearly Current Assets VS Current LiabilitesHZO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The earnings per share for HZO have decreased strongly by -56.03% in the last year.
Measured over the past 5 years, HZO shows a small growth in Earnings Per Share. The EPS has been growing by 5.01% on average per year.
Looking at the last year, HZO shows a decrease in Revenue. The Revenue has decreased by -5.78% in the last year.
The Revenue has been growing by 14.46% on average over the past years. This is quite good.
EPS 1Y (TTM)-56.03%
EPS 3Y-32.09%
EPS 5Y5.01%
EPS Q2Q%-67.55%
Revenue 1Y (TTM)-5.78%
Revenue growth 3Y5.62%
Revenue growth 5Y14.46%
Sales Q2Q%-13.27%

3.2 Future

HZO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.17% yearly.
HZO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.34% yearly.
EPS Next Y-63.32%
EPS Next 2Y-6%
EPS Next 3Y9.17%
EPS Next 5YN/A
Revenue Next Year-6.7%
Revenue Next 2Y-1.57%
Revenue Next 3Y0.34%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HZO Yearly Revenue VS EstimatesHZO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
HZO Yearly EPS VS EstimatesHZO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

HZO is valuated rather expensively with a Price/Earnings ratio of 22.80.
Based on the Price/Earnings ratio, HZO is valued a bit cheaper than 68.85% of the companies in the same industry.
HZO's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.06.
With a Price/Forward Earnings ratio of 13.75, HZO is valued correctly.
Based on the Price/Forward Earnings ratio, HZO is valued a bit cheaper than the industry average as 72.95% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of HZO to the average of the S&P500 Index (22.64), we can say HZO is valued slightly cheaper.
Industry RankSector Rank
PE 22.8
Fwd PE 13.75
HZO Price Earnings VS Forward Price EarningsHZO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HZO is valued cheaply inside the industry as 90.16% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.93
HZO Per share dataHZO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)4.55
EPS Next 2Y-6%
EPS Next 3Y9.17%

0

5. Dividend

5.1 Amount

HZO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MARINEMAX INC

NYSE:HZO (9/25/2025, 7:25:14 PM)

After market: 25.76 0 (0%)

25.76

-0.24 (-0.92%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)07-24 2025-07-24/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners95.79%
Inst Owner Change-0.78%
Ins Owners3.04%
Ins Owner Change-5.71%
Market Cap552.81M
Analysts81.67
Price Target34.34 (33.31%)
Short Float %18.15%
Short Ratio10.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.16%
Min EPS beat(2)-59.12%
Max EPS beat(2)83.44%
EPS beat(4)2
Avg EPS beat(4)48.21%
Min EPS beat(4)-59.12%
Max EPS beat(4)189.48%
EPS beat(8)3
Avg EPS beat(8)6.98%
EPS beat(12)5
Avg EPS beat(12)4.55%
EPS beat(16)9
Avg EPS beat(16)9.43%
Revenue beat(2)1
Avg Revenue beat(2)-2.21%
Min Revenue beat(2)-12.47%
Max Revenue beat(2)8.06%
Revenue beat(4)1
Avg Revenue beat(4)-3.31%
Min Revenue beat(4)-12.47%
Max Revenue beat(4)8.06%
Revenue beat(8)4
Avg Revenue beat(8)-0.15%
Revenue beat(12)6
Avg Revenue beat(12)-0.01%
Revenue beat(16)8
Avg Revenue beat(16)-0.32%
PT rev (1m)0%
PT rev (3m)-0.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-142.75%
EPS NY rev (1m)0%
EPS NY rev (3m)-59.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.09%
Valuation
Industry RankSector Rank
PE 22.8
Fwd PE 13.75
P/S 0.24
P/FCF N/A
P/OCF 52.29
P/B 0.59
P/tB 1.47
EV/EBITDA 4.93
EPS(TTM)1.13
EY4.39%
EPS(NY)1.87
Fwd EY7.27%
FCF(TTM)-2.5
FCFYN/A
OCF(TTM)0.49
OCFY1.91%
SpS108.12
BVpS43.83
TBVpS17.55
PEG (NY)N/A
PEG (5Y)4.55
Profitability
Industry RankSector Rank
ROA -1.08%
ROE -2.85%
ROCE 7.75%
ROIC 3.78%
ROICexc 4.06%
ROICexgc 5.57%
OM 5%
PM (TTM) N/A
GM 32.41%
FCFM N/A
ROA(3y)6.87%
ROA(5y)9.12%
ROE(3y)13.71%
ROE(5y)16.71%
ROIC(3y)9.69%
ROIC(5y)12.16%
ROICexc(3y)11.72%
ROICexc(5y)15.7%
ROICexgc(3y)16.73%
ROICexgc(5y)22.44%
ROCE(3y)16.44%
ROCE(5y)19.71%
ROICexcg growth 3Y-46.03%
ROICexcg growth 5Y-2.42%
ROICexc growth 3Y-44.7%
ROICexc growth 5Y-7.52%
OM growth 3Y-19.61%
OM growth 5Y1.53%
PM growth 3Y-40.71%
PM growth 5Y-11.66%
GM growth 3Y1.03%
GM growth 5Y4.78%
F-Score4
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF N/A
Debt/EBITDA 6.72
Cap/Depr 134.26%
Cap/Sales 2.77%
Interest Coverage 1.5
Cash Conversion 6.45%
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 0.29
Altman-Z 1.82
F-Score4
WACC9.15%
ROIC/WACC0.41
Cap/Depr(3y)198.93%
Cap/Depr(5y)172.82%
Cap/Sales(3y)2.58%
Cap/Sales(5y)1.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.03%
EPS 3Y-32.09%
EPS 5Y5.01%
EPS Q2Q%-67.55%
EPS Next Y-63.32%
EPS Next 2Y-6%
EPS Next 3Y9.17%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.78%
Revenue growth 3Y5.62%
Revenue growth 5Y14.46%
Sales Q2Q%-13.27%
Revenue Next Year-6.7%
Revenue Next 2Y-1.57%
Revenue Next 3Y0.34%
Revenue Next 5YN/A
EBIT growth 1Y-14.52%
EBIT growth 3Y-15.1%
EBIT growth 5Y16.21%
EBIT Next Year-13.84%
EBIT Next 3Y9.34%
EBIT Next 5YN/A
FCF growth 1Y82.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.35%
OCF growth 3YN/A
OCF growth 5YN/A